Accessibility Tools
Breaking News: Myonex appoints Greg Lavin as Chief Executive Officer as James Lovett retires, joins Board of Directors
With an industry that is constantly changing and evolving, the Myonex team can be your trusted source to identify the right solutions for your projects from clinical to commercial stages. Stay up to date with our latest company news announcements.
Myonex updates
DELPHARM & CREAPHARM announced they have successfully joined forces to better serve HMNC Brain Health and met the FPI deadline in its BH-200-03 European phase 2 clinical trial.
Ancillary supply
Myonex featured in ACT: Overcoming Challenges Associated with Ancillary Supply Management
Myonex Awarded as “Top Workplace in the Philadelphia Region” for The Second Year in a Row
Biobanking
The French-speaking Diabetes Society is seeking the expertise of three leaders in the French biobanking ecosystem to accelerate the identification of new factors associated with major cardiovascular events (MACE*) in patients.
Myonex completes acquisition of Hubertus Clinical Trial and Packaging Business
CTRx®
Myonex Launches CTRx Europe, Central Pharmacy Network
Clinical trial supply optimization
Myonex Featured In International Clinical Trials Magazine
Myonex Among Inquirer’s Top 5 Best Workplaces
Creapharm Demonstrates Unparalleled Performance Of -80°C Nitrogen Tank Technology
Myonex awarded Bronze EcoVadis Score in recognition of their sustainability efforts
Nitrogen Tanks -80°C For Highly- Secure Storage, A First In France
Myonex to Acquire Clinical Trial and Drug Wholesale Business of Hubertus in Berlin